Skip to main content

Table 3 Clinical Characteristics and laboratory profile of ART patients in relation to the parasite positivity rate in St. Mary Aksum General Hospital, from March to April 2017 Tigray, Ethiopia

From: Intestinal parasitosis in relation to CD4 count and anemia among ART initiated patients in St. Mary Aksum general hospital, Tigray, Ethiopia

Variables   Frequency (%) Positive to IPIs, n (%)
Start of ART Less than one year 11(4.5) 4(36.4)
before one year 231(95.5) 60(26.0)
Current WHO HIV stage I 236 (97.5) 63(26.7)
II 3(1.2) 1(33.3)
III 3(1.2) 0(0.0)
Type of ARV drug First line 224(92.6) 57(25.4)
Second line 18(7.4) 7(38.9)
Category of CD4 now < 200 39(16.1) 18(46.2)
200–500 69(28.5) 16(23.2)
500+ 134(55.4) 30(22.4)
Stool consistency Formed 69(28.5) 8(11.6)
Soft 101(41.7) 26(25.7)
Loose 44(18.2) 17(38.6)
Diarrheic 28(11.6) 13(46.4)
Diarrhea condition No diarrhea 214(88.4) 51(23.8)
Chronic 17(7.0) 8(47.1)
Acute 11(4.6) 5(45.5)
Anemia status No anemia 215(88.8) 49(22.8)
Mild 20(8.3) 10(50.0)
Moderate 7(2.9) 5(71.4)
Presence of Parasites Yes 64(26.4) 64(26.4)
No 178(73.6) 178(73.6)
Total   242(100) 64 (26.4%)
  1. Note: ART Antiretroviral Therapy, ARV Antiretroviral, IPs Intestinal parasites